Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Started: Ginandmilk, 14 Jun 2024 10:26
Last post: platoh, 26 Jun 2024 12:51
And yet
Good write up by hardman and co
“…normally is moved…”
Hopefully we'll be back on the front foot soon.
The sales were on 18th June. The share price reached a high of 70p on 7th June, falling to 63 on 17th June.
I think the problem the directors face is that they become liable for tax when the options vest, so need to sell some shares to cover the tax payments.
Given that 665k shares hit the market, which normally is over by a trade of just a few thousands, I think the share price held up very well. No doubt one of the IIs bought them.
Last post: Washerupper, 24 Jun 2024 22:35
That’s a circa 850k shares purchase, which I don’t recall seeing go through. Good to see.
Holdings show a add.. Bodes well..
Started: StuoftheToon, 14 Jun 2024 07:08
Last post: izstar, 14 Jun 2024 09:23
Agree - implies steady as she goes growth - key update coming up
Lots of positives to take from this short note, leaving me reassured ahead of the next trading update.
Yes so well run - they have sight of all the components of their business - a company I have always actually enjoyed being part of and intend to stay part of for many years to come
Another good move by the Board.
Started: platoh, 31 May 2024 11:00
Last post: lenlenlen, 31 May 2024 12:57
Often good companies on AIM are squashed for years as the major indexes are in consolidation. They almost always follow
The major markets. FTSE reaching all time highs and breaking out, along with the S&P should see any legitimate AIM companies moving up. Clearly TRX is undervalued so it should move well if major markets continue.
Oops . I foolishly assumed Google would serve me a recent news item as first search result.
Was looking for a reason for the recent increased interest.
That's a Tuesday in 2015 lol...but does show the hard work and regulatory approvals that are in the bank with TRX
Https://uk.news.yahoo.com/finance/news/tissue-regenix-jumps-acl-treatment-150700445.html
Shares in Tissue Regenix jumped on Tuesday, after the producer of devices for regenerative medicine said it had taken a "critical step" towards securing approval for a new treatment. The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has given the green light to the first stage of clinical trials on the company's Orthopure XT
Started: Sambaqueen01, 27 May 2024 09:49
Last post: platoh, 31 May 2024 10:56
+10% a week for a few weeks would be quite acceptable
Moving at last! Hope it continues for a few weeks.
They have been achieving 20% growth for a while now, it depends on how long they can keep this rate up. Given the relative size of revenues and Mcap I would think another year or two at least. So approx 36M USD for 2024?
The biggest mover will be if any progress is made on this from Daniel Lee’s section of the last full year results:
In 2024, we will begin some of the preliminary planning activities to build our Phase 2 capacity expansion. In addition to our organic growth plans, we will continue to examine acquisition opportunities that would allow us to scale the business for additional longer-term growth.
Any move to expand, and provide further fuel to revenue growth will be an opportunity for the market to reassess TRX’s worth.
Bottom line is this could ten-times from here and still be below most investors’ radar. If management continue to grow this company and maintain the sensible strategy they have exemplified for the last few years, then I am happy to hold for years to come.
Based on the report by Hardman associates they predict total 2024 revenues of $34.5. I think H2 will be stronger than H1.
H2 2023 was .$15.4 as nd a growth of expected 20% would suggest H1 2024 of $18.4 million.
My earlier prediction of 2024 revenue of $40 million.
I think this will be trading at £ 80p by July update. £1.20 by full year results.
Thoughts?
Shock.. I am in the blue... Only have a few now sonot a life changer though..
Started: StuoftheToon, 31 May 2024 09:06
Last post: izstar, 31 May 2024 09:23
Me neither - my biggest and longest held holding
When management, workforce, product and demand all align it was indeed only a matter of time
Such an unusual share for aim
The twin emotions of TRX holders:
60p: this so frustrating, I should just sell up.
70p: why didn't I add more at 60p!?
:)
It's good to see this moving up. It was always going to happen, it's just a question of patience. A great product, strong niche/moat, great mgmt. The dull periods are a blessing for PIs, rather than a curse, because it allows us time to load up.
60p/70p, I'm still not selling.
Can we break 70p???
Started: Yorkshireboy, 28 May 2024 09:16
Last post: Yorkshireboy, 28 May 2024 09:16
today, tissue regenix ceo daniel lee introduced a talk about hashtag#orthopure xt at the geistlich pharma lunchtime symposium at the esska - european society of sports traumatology, knee surgery & arthroscopy congress in milan, italy.
prof. stefano zaf***nini also shared his experiences and short-term results with orthopure xt for hashtag#acl reconstruction.
for more information, please visit the website: https://lnkd.in/ekzzanby
hashtag#esska2024
hashtag#esskacongress
Started: bottom_feeder, 9 May 2024 14:00
Last post: izstar, 20 May 2024 20:22
Well said Covgas - lth here and patient as you like! Should be getting close to something significant here if they maintain rate of current growth
Gl all
IMO this isn't down to PI's , they haven't enough clout. One day the institutions are going to buy big , when they see the signals they are looking for , then we are on for one helluva ride.
You got be innit to win it.
Richard Sneller was buying up until end of February, and Lombard Odier has been increasing their stake (up 0.45% in April), as far as I can see.
The share price will move up when PIs see a reason to buy in - maybe at the next trading update (mid July?).
Ejackson
'patience will be rewarded in multiples of today's SP'
I certainly hope you're right. Mine is being tested to the limit with TRX!
Apologies, I was referencing the latest presentation/ TU
Started: Thompi, 7 May 2024 18:29
Last post: Thompi, 7 May 2024 18:29
TRX are nominated in two categories:
Best Communication Award
Chief Executive of the Year
https://www.mediscience-event.co.uk/nominations-overview/
So frustrating - the sp is stuck on 61p - just don't understand given years of growth - guess they need to transition into true profitability not EBITA profitability but even so SP should be at £1 given all they have achieved - what is holding it back?
Yes I definitely voted in favour of all resolutions.
Very much support their focus and direction and agree re the web site - parts of it are out of date - looks sloppy.
I seem to remember getting something from IG. I just voted for everything , sorry I can't remember what the votes were for.
Basically , with 99+% of all resolutions passed we are just invited to vote to adhere to the law imo, we can make no difference.
In reply to the person who thinks we had movement today , we didn't. It was marked down 2.16 % the other day , the price on LES didn't change. It has been marked up the same today , the price hasn't changed.
Patience of a Saint required. Knowing when to sell will be my biggest problem.
If it spikes 40% which is quite possible , do I sell? It will get sold into , but will that be a trapdoor me to think the sp is falling off again.
Only to rerate by 200% within a week. That is the scenario I am sort of expecting.
When is another question.
Maybe I missed something, but I don't recall, nor can I find, any communications giving the resolutions at the AGM. The TRX website doesn't show anything that I can find, only AGMs up to 2023. Nothing on my dealing site either.
Has anyone received/seen anything? I'd like to know what the resolutions are (I'd like to have had an opportunity to vote on them!).
And on the subject of the company web site, if anyone from TRX is reading this, please bring it up to date.
Started: MrTibs, 19 Mar 2024 13:47
Last post: MrTibs, 25 Apr 2024 12:27
Movement hooray!!!!
Were they a buy at 73?
I haven't sold any , I thought I made my stance clear?
This time the top was 73 , it was pretty obvious even to a fool like me.
If you couldn't see that then don't ask.
Just now, I'd rate them a buy. It's a very thinly traded stock, and the share price always drops after results as the short term traders unload their speculative holdings. It'll drift up again in the coming months to a new high prior to the next trading update in July. Thereafter, falling back again - unless, of course, there's some really good news in the update, in which case you'd kick yourself for having sold too early :-)
If you do spot a high again, please let us all know before it passes ;-)
I feel your pain, but be patient. This will either re-rate during this year, be taken over or be taken private (I hope not the latter). The small market cap and low volumes does make it difficult for II. A duel Nasdaq listing would be good, but I’m not sure what hurdles need to be overcome for that.
Last post: You_Having_a_Laugh, 19 Apr 2024 16:15
You read people touting a move to a US listing as the solution to all problems. Liquidity is better and there is multiple expansion. The multiple expansion will come and bite where it hurts when the inevitable contraction happens and the liquidity acts in both directions.
Better for TRX to stay where it is and wait and let it work itself out and for the patient to buy at bargain prices.
Totally understandable, but I would sit tight. The company is doing well. I think we all recognise that the suitability of the aim will be under review, and a Nasdaq listing (either joint or as an alternative) seems obvious once appropriate. It is operationally a US company after all. A takeover or being taken private (with a view to a US listing) are other potentials. Being taken private or sole Nasdaq listing has obvious drawbacks for uk PIs re ISAs
I have sold on third of my holding here. After three years I still showed a small loss but the market shows no interest in this company. I fear it might move to America before some large pharma snaps it up.
Risk adversion is becoming dire..... I still have the other two thirds because I can see nothing better to buy! I really hope something changes.
Last post: izstar, 19 Apr 2024 06:07
Yes markets in the doldrums - in other times the growth story here would have been richly rewarded. IMO it will happen soon enough - maybe a move from aim to nasdaq? The fact they can’t raise prices shows how competitive their market is so surely their being bought with less resulting less competition/economy of scale makes sense?
118 shares traded today in TRX , says it all really. Hopefully a takeover will be in the offing .
Before anyone says , I'm not suggesting we are listed on the FTSE ,AIM is worse!
The UK market is an ass, that's why many companies are leaving the UK. The FTSE doesn't even track the Dow now like it used to in the 90's. The FTSE is way below the valuation of the Dow.
The only time TRX will be valued correctly is if a takeover happens , otherwise UK hasn't a clue how to value anything.
I think that is the key point - I thought for many years they would have to raise again when they expanded and they have now ruled that out. Not only is that almost unique in an AIM share it also confirms management's confidence in themselves, their employees and the business
Started: spindok, 11 Apr 2024 08:24
Last post: spindok, 11 Apr 2024 08:24
For three years I have held this share. So far I have nothing to show. The sp is moribund. However I do believe that the sun will come out tomorrow.... Its just a matter of living long enough to enjoy it. Talk over 2 pounds or four is just idle dreaming...Sometimes though dreams come true
Last post: izstar, 6 Apr 2024 21:50
Poetically put and totally agree
Like a fine bottle of Champagne, the cork is being eased out and when it’s ready it will pop. All the right things being done by management, institutions seeing the value which only reduces the free float meaning when this company’s value is realised it will fly.
Started: platoh, 5 Apr 2024 16:21
Last post: Mafuta, 5 Apr 2024 20:36
Founded in 1796, Lombard Odier is the oldest private bank in Geneva and one of the largest in Switzerland and in Europe ... sounds good to me. LH&K Mafuta
Good to see Lombard Odier steadily increasing their stake: 10.01% last year, 10.75% in February, now 11.03%
Totally agree. I just hold them and wait...
Started: DANNYBAREY, 19 Mar 2024 22:00
Last post: DANNYBAREY, 19 Mar 2024 22:00
Last post: spindok, 19 Mar 2024 17:26
Just imagine if it was bad news.....ahhhh
Started: platoh, 19 Mar 2024 08:00
Last post: Washerupper, 19 Mar 2024 12:33
They reiterated their guidance from last year. I thought they would upgrade it to 4x fwd sales, but they have left it at 120p. I missed the investors call but will look at a recording shortly.
On first glance the SP has already responded to the excellent company performance - up from 51p on January 19th.
But what we are seeing is simply recovery after last years share consolidation, therefore, the SP should have much further to go in 2024.
Volume has been better since January, but needs to increase substantially for the SP too really take off as it should.
What we need to see is new investors building substantial long term stakes in the company - this will be the game changer.
Cheers
If sp continues to fail to reflect underlying business perhaps TRX will be bought - I hope not as a great company to own a small piece of but would allow them to grow more quickly
@washerupper - the 120p target price, is that set for this year? Haven't been doing much reading up lately.
Started: Banditkong, 19 Mar 2024 07:17
Last post: platoh, 19 Mar 2024 08:45
Last chance to buy at these low, low prices :-)
Great set of results. This share is surely due a re-rate. LH&K Mafuta
all credit to daniel lee, david ****e and the team - great set of results and very impressive continuity rewarded by the positive ebitda.
Also good to see SGA costs as a percentage of revenue falling year on year
Yes just superb - an aim share where you can sleep well the night before results
Another winning year but so much more - no equity funding for expansion plans next year, moving to medical devices entity , all sorts of initiatives - these results are stuffed full of optimism. What a company - great directors leading a highly motivated and engaged work force
I do not want to go to the moon. I just want to stay in the black. First read seems quite ok..
Started: StuoftheToon, 18 Mar 2024 12:40
Last post: covgaz, 18 Mar 2024 17:56
Unfortunately we all knows what happens on results day , we needed to be higher to absorb it. It'll come .....one day.
I feel like Schrödinger’s investor. I am either a happy bunny or a disappointed rabbit. I’ll know tomorrow when they open the results box.
Sums up the state of AIM at present that TRX are trading at the same valuation as 3 years ago, despite clearly executing on all fronts and not returning to the market for capital. If this can break 70p tomorrow then it could rerate quite significantly IMO. Pre Woodford / Invesco dump & subsequent funding issues (which likely wouldn't have happened if Woodford hadn't gone to the wall) this was a £100m+ market cap which was a long way from profitability!
Hoping for a little bit of interest here before tomorrow's results (hopefully not everything is already priced in). GLA.
Started: spindok, 18 Mar 2024 10:07
Last post: izstar, 18 Mar 2024 12:09
I truly hope you are right. Business has grown qtr to qtr with new products and territories to come and led by competent managers - fingers crossed
Oh well this time tomorrow we will have digested the final results. This is not hardly noticed except by a few canny large holders.. May be proved wrong but the last year the sp has been moribund. I think it will prove the quiet before the storm...